AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

Also called NCT07512206

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
OPCI Core Laboratories LLC (from the registry)
Registry
  • NCT NCT07512206
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07512206. Allocation not applicable; no masking; primary purpose treatment. Start 2026-04-01 (anticipated); primary completion 2026-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease
Acronym
AERO CAD
Condition
Coronary Calcification
Condition
Coronary Calcified Disease
Condition
Coronary Calcified Nodules
Intervention (Device)
Shockwave C2 Aero Coronary IVL System
Lead sponsor
OPCI Core Laboratories LLC (class: other)

Record details

Record id
cardio:ct-nct07512206
Content hash
71922765d5a08d0fd592d9cc4ceca893f46bfaf878605328feea9003a2c3b450